Latest Form 4 insider transactions

NASDAQ
Jennifer A Baldock, a Director of Katapult Holdings, Inc., received 596,320 shares of common stock on August 11, 2026.
NASDAQ
IQV Holdco, LLC and 1 other reported changes in beneficial ownership of Katapult Holdings, Inc. common stock on August 11, 2026.
NASDAQ
Brannin Mcbee, Chief Development Officer of CoreWeave, Inc., sold 197,000 shares of common stock on August 10, 2026.
NASDAQ
Bosch John Roderick Ten, SVP of Laboratory Operations of BillionToOne, Inc., sold 1,417 shares of common stock on August 10, 2026 for $92.86 per share.
NASDAQ
Joseph D Mansueto, Executive Chairman, a Director and 10% owner of Morningstar, Inc., sold 15,474 shares of common stock on August 10, 2026.
OQB
Garo H Armen, EXEC. CHAIR & PRINCIPAL OFF and a Director of Protagenic Therapeutics, Inc.new, purchased 2,220 shares of common stock on August 11, 2026 for $0.32 per share.
NASDAQ
David Tsao, Chief Technology Officer and a Director of BillionToOne, Inc., sold 10,000 shares of common stock on August 10, 2026 for $92.86 per share.
NASDAQ
Glenn H Hutchins, a Director of CoreWeave, Inc., reported multiple transactions in common stock on August 10, 2026.
NASDAQ
Serhii Kupriienko, a Director and 10% owner of Swarmer, Inc, reported multiple transactions in common stock on August 9, 2026.
AMEX
Kannan Sugantharaman, CFO and COO of Mastech Digital, Inc., received 20,000 shares of common stock on August 10, 2026.
NYSE
Bill Wilson, Chief Executive Officer, a Director and 10% owner of Townsquare Media, Inc., sold 148,164 shares of common stock on August 11, 2026.
NASDAQ
Dinesh V Ph D Patel, President and CEO and a Director of Protagonist Therapeutics, Inc, sold 100,000 shares of common stock on August 10, 2026.
NASDAQ
Marshall Fordyce, PRESIDENT AND CEO and a Director of Vera Therapeutics, Inc., sold 46,250 shares of common stock on July 7, 2026.
NASDAQ
Marshall Fordyce, PRESIDENT AND CEO and a Director of Vera Therapeutics, Inc., sold 18,500 shares of common stock on June 23, 2026.
NASDAQ
Marshall Fordyce, PRESIDENT AND CEO and a Director of Vera Therapeutics, Inc., sold 18,500 shares of common stock on May 12, 2026.
NASDAQ
Ajay K Amlani, President & CEO and a Director of Aware Inc /Ma/, purchased 6,103 shares of common stock on August 10, 2026.
NYSE
Mario Rizzo, Chief Operating Officer-AIC of Allstate Corp, sold 56,225 shares of common stock on August 11, 2026.
NYSE
Patricia K Wagner, a Director of Primoris Services Corp, reported a transaction in 2,241 shares of common stock on August 11, 2026.
NASDAQ
Ilan Feuchtwang, Chief Legal Officer, Secretary of Cytek Biosciences, Inc., reported multiple transactions in common stock on August 10, 2026.
NYSE
John Kristofer Galashan, a Director of Life Time Group Holdings, Inc., sold 5,119,099 shares of common stock on August 10, 2026 for $43.16 per share.
NASDAQ
John C Malone, a Director and 10% owner of GCI Liberty, Inc., purchased 542,232 shares of common stock on August 10, 2026.
NYSE
James A. Sullivan, President and CTO of Koppers Holdings Inc., sold 7,500 shares of common stock on August 11, 2026 for $50.00 per share.
NASDAQ
Francine Sullivan, Chief Legal Officer of EVgo Inc., reported multiple transactions in common stock on August 10, 2026.
NASDAQ
Dennis G Kish, President of EVgo Inc., reported multiple transactions in common stock on August 10, 2026.
NYSE
Nechemia Jacob Peres, a Director of Via Transportation, Inc., purchased 10,080 shares of common stock on August 11, 2026 for $24.74 per share.
NASDAQ
Karim Wagdy Hamed, SVP & GM Semiconductor Busines of Littelfuse Inc /De, reported a transaction in 141 shares of common stock on August 11, 2026.
NYSE
Andrew Labenne, Chief Financial Officer of LendingClub Corp, sold 13,929 shares of common stock on August 10, 2026 for $19.37 per share.
Whitney O Cluff, a Director of Inception Mining Inc., reported multiple transactions in common stock on May 13, 2026.
NASDAQ
Katherine Schuelke, a Director of SITIME Corp, sold 500 shares of common stock on August 11, 2026 for $698.05 per share.
NASDAQ
Lionel Bonnot, See Remarks of SITIME Corp, sold 1,500 shares of common stock on August 10, 2026 for $725.00 per share.